# PhenoMx, Inc.

> PhenoMx, Inc. is a New York digital health company turning ordinary MRI scanners into a 'Personalized Digital Physical Exam.' Its software-first platform applies quantitative imaging and machine learning to non-invasive MRI scans, measuring organs, tissues, body composition, brain, heart and joints over time. Founded in 2017 by Mark Punyanitya and Girish Srinivasan, PhenoMx aims to make precision medicine accessible far beyond the wealthy - from concierge athletes to value-based care and clinical trials worldwide.

- **Founded:** 2017
- **Headquarters:** New York, New York, United States
- **Founders:** Mark Punyanitya (Co-Founder, President & CEO), Girish Srinivasan (Co-Founder & Chief Technical Officer), Zachary Rapp (Co-Founder & Advisor), Andrew Bogle (Co-Founder & Advisor)
- **Team size:** 4-10 employees
- **Products:** Personalized Digital Physical Exam, Quantitative Imaging Platform (PaaS), Population Health Solutions, Individual & Concierge Health, Clinical Trials Services
- **Notable:** Founder Mark Punyanitya has published 40+ peer-reviewed papers on body composition applied across therapeutic areas., Built a software-first platform that works on legacy MRI scanners, lowering the barrier to quantitative imaging., Presented at Precision Medicine World Conference (PMWC) and Precision Medicine USA congresses.

## Products & services

- **Personalized Digital Physical Exam** — A non-invasive, whole-body MRI-based exam that measures major vital organs and tissues - body composition, cardiac structure, brain and spine, joints and organs - and tracks phenotypic changes over time.
- **Quantitative Imaging Platform (PaaS)** — Software-first platform that runs on existing/legacy MRI infrastructure, automating image processing and generating physician-ready reports without requiring new hardware.
- **Population Health Solutions** — Quantitative imaging deployed to measure the impact of social determinants of health and support value-based care models across populations.
- **Individual & Concierge Health** — Personalized assessments for individuals and high-performance athletes seeking early screening, risk prediction and longevity insight.
- **Clinical Trials Services** — Standardized, quantitative imaging endpoints and body-composition analysis for pharma and CRO clinical trials across therapeutic areas.

## Achievements

- Founder Mark Punyanitya has published 40+ peer-reviewed papers on body composition applied across therapeutic areas.
- Built a software-first platform that works on legacy MRI scanners, lowering the barrier to quantitative imaging.
- Presented at Precision Medicine World Conference (PMWC) and Precision Medicine USA congresses.
- Co-authored research on accuracy and precision of 3D optical imaging for body composition (medRxiv, 2022).
- Expanded internationally with collaborations involving S3 Group and the Chinese Academy of Sciences.

## Latest updates

- **2021-12** — Reported total funding of $4.65M (Series A stage) to scale its quantitative imaging platform.
- **2022-11** — Co-authored medRxiv research on 3D optical imaging accuracy for body composition across age, BMI and ethnicity.

## Links

- Website: https://phenomx.co
- LinkedIn: https://www.linkedin.com/company/phenomx
- Twitter/X: https://twitter.com/PhenoMxInc

---

Profile page: https://yespress.io/phenomx-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-13